
CAS 95716-98-6
:Fórmula:C24H31KO7
InChI:InChI=1S/C24H32O7.K/c1-21-7-4-14(25)10-13(21)11-15(20(28)30-3)19-16-5-8-23(29,9-6-18(26)27)22(16,2)12-17-24(19,21)31-17;/h10,15-17,19,29H,4-9,11-12H2,1-3H3,(H,26,27);/q;+1/p-1/t15-,16+,17-,19+,21+,22+,23-,24-;/m1./s1
Clave InChI:PRKXKJMKEHYPBV-PUDZRVQSSA-M
SMILES:C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@]5(CCC(=O)[O-])O)C)C(=O)OC.[K+]
Filtrar por
Porcentaje de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Se han encontrado 5 productos.
- Precio más bajo
- Precio más alto
- Pureza más baja
- Pureza más alta
- Entrega estimada más rápida
Eplerenone EP Impurity F Potassium salt
CAS:Fórmula:C24H31O7·KForma y color:White To Off-White SolidPeso molecular:431.51 39.109,11α-Epoxy-17-hydroxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21-carboxylic Acid Potassium Salt
CAS:Fórmula:C24H31O7·KForma y color:NeatPeso molecular:470.6Eplerenone Hydroxyacid Potassium Salt
CAS:Producto controladoApplications A metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.
References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),Fórmula:C24H31O7·KForma y color:NeatPeso molecular:470.6Eplerenone-methyl-d3 Hydroxyacid Potassium Salt
CAS:Producto controladoApplications A labelled metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.
References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),Fórmula:C24D3H28KO7Forma y color:NeatPeso molecular:473.615Eplerenone hydroxyacid potassium salt
CAS:Eplerenone is a drug that belongs to the class of drugs known as selective mineralocorticoid receptor antagonists. It is a prodrug that is metabolized in vivo to its active form, eplerenone acid. Eplerenone inhibits the binding of aldosterone to its receptors in the kidney. Eplerenone hydroxyacid potassium salt has been shown to have stereochemical purity of >98% and no detectable process-related impurities or experimental impurities. High-performance liquid chromatography (HPLC) methods have been used to characterize this drug substance and confirm that it has an average particle size 10 micrometers with no particles > 150 micrometers.Fórmula:C24H31KO7Pureza:Min. 95%Peso molecular:470.6 g/mol



